US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:OCX
Recent news which mentions NASDAQ:OCX
OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
Tickers
OCX
Tags
Earnings Reports
OCX
NASDAQ:OCX
From
InvestorPlace
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Tickers
BIO
OCX
Tags
NASDAQ:OCX
From
News Direct
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Tickers
OCX
Tags
Earnings Reports
OCX
NASDAQ:OCX
From
InvestorPlace
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023
April 12, 2024
Tickers
OCX
Tags
Earnings Reports
OCX
NASDAQ:OCX
From
InvestorPlace